SHTDY:OTCMKTS
Sinopharm
၉.၃၆ US$
arrow_upward
+၀.၃၅%(+၀.၀၃၃) 1D
အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SHTDY...
Open
၉.၃၈ US$
High
၉.၇၂ US$
Low
၉.၃၁ US$
Mkt. cap
ဋေ ၄.၅၇ ထ
Avg. vol.
၁.၉၃ သိန်း
Volume
၁.၁၉ သိန်း
52-wk high
၁၄.၈၇ US$
52-wk low
၉.၀၅ US$
Beta
၀.၁၀
Shares outstanding
၂၆.၈၄ ကုဋေ
No. of employees
၉ သောင်း
Open
၉.၃၈ US$
High
၉.၇၂ US$
Low
၉.၃၁ US$
Mkt. cap
ဋေ ၄.၅၇ ထ
Avg. vol.
၁.၉၃ သိန်း
Volume
၁.၁၉ သိန်း
52-wk high
၁၄.၈၇ US$
52-wk low
၉.၀၅ US$
Beta
၀.၁၀
Shares outstanding
၂၆.၈၄ ကုဋေ
No. of employees
၉ သောင်း
News stories
From web sources and news partners
Yahoo! Finance Canada
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
CABA,TRIN,RPC,FFIN,NXRT,GO,BLCO,CULP,VSNT,FRST,VIRC,KWY,ENTX,GRNT,BLIN,SSP,PCF,GAIA,AFCG,NRGV,APCX,THRY,KLTR,BETR | Stock Prices | Quote Comparison
Cryptonews.net
·
ပြီးခဲ့သည့် ၈ မိနစ်
OKX, NYSE parent file to launch tokenized US stock platform
Korea JoongAng Daily
·
ပြီးခဲ့သည့် ၁ နာရီ
SK hynix shareholders move to block Solidigm Nasdaq listing over dilution fears
MSN
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Spiking bond yields, midterms, earnings to test US stocks' typical fourth-quarter strength
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm